1. Home
  2. UCL vs IXHL Comparison

UCL vs IXHL Comparison

Compare UCL & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uCloudlink Group Inc.

UCL

uCloudlink Group Inc.

HOLD

Current Price

$1.40

Market Cap

52.8M

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$2.72

Market Cap

45.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCL
IXHL
Founded
2014
2001
Country
Hong Kong
Australia
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
52.8M
45.0M
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
UCL
IXHL
Price
$1.40
$2.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.4K
652.3K
Earning Date
05-20-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,000.00
Revenue This Year
$11.60
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$0.11
52 Week High
$4.19
$6.39

Technical Indicators

Market Signals
Indicator
UCL
IXHL
Relative Strength Index (RSI) 40.38 48.46
Support Level $1.23 $0.34
Resistance Level $1.67 $3.68
Average True Range (ATR) 0.08 0.32
MACD 0.00 -0.16
Stochastic Oscillator 45.90 18.49

Price Performance

Historical Comparison
UCL
IXHL

About UCL uCloudlink Group Inc.

Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: